Correlation Between Edgewise Therapeutics and NLS Pharmaceutics
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and NLS Pharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and NLS Pharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and NLS Pharmaceutics AG, you can compare the effects of market volatilities on Edgewise Therapeutics and NLS Pharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of NLS Pharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and NLS Pharmaceutics.
Diversification Opportunities for Edgewise Therapeutics and NLS Pharmaceutics
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Edgewise and NLS is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and NLS Pharmaceutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NLS Pharmaceutics and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with NLS Pharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NLS Pharmaceutics has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and NLS Pharmaceutics go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and NLS Pharmaceutics
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 0.63 times more return on investment than NLS Pharmaceutics. However, Edgewise Therapeutics is 1.59 times less risky than NLS Pharmaceutics. It trades about 0.08 of its potential returns per unit of risk. NLS Pharmaceutics AG is currently generating about -0.02 per unit of risk. If you would invest 798.00 in Edgewise Therapeutics on September 3, 2024 and sell it today you would earn a total of 2,502 from holding Edgewise Therapeutics or generate 313.53% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. NLS Pharmaceutics AG
Performance |
| Timeline |
| Edgewise Therapeutics |
| NLS Pharmaceutics |
Edgewise Therapeutics and NLS Pharmaceutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and NLS Pharmaceutics
The main advantage of trading using opposite Edgewise Therapeutics and NLS Pharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, NLS Pharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NLS Pharmaceutics will offset losses from the drop in NLS Pharmaceutics' long position.| Edgewise Therapeutics vs. DiaMedica Therapeutics | Edgewise Therapeutics vs. Lyra Therapeutics | Edgewise Therapeutics vs. Centessa Pharmaceuticals PLC |
| NLS Pharmaceutics vs. Neurobo Pharmaceuticals | NLS Pharmaceutics vs. Indaptus Therapeutics | NLS Pharmaceutics vs. Pasithea Therapeutics Corp | NLS Pharmaceutics vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |